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ABSTRACT
Non-coding (nc) RNAs are increasingly recognized
to play important regulatory roles in eukaryotic
gene expression. The highly abundant and essential
7SK ncRNA has been shown to negatively regulate
RNA Polymerase II transcription by inactivating the
positive transcription elongation factor b (P-TEFb) in
cellular and Tat-dependent HIV transcription. Here,
we identify a more general, P-TEFb-independent
role of 7SK RNA in directly affecting the function
of the architectural transcription factor and chroma-
tin regulator HMGA1. An important regulatory role
of 7SK RNA in HMGA1-dependent cell differentiation
and proliferation regulation is uncovered with the
identification of over 1500 7SK-responsive HMGA1
target genes. Elevated HMGA1 expression is
observed in nearly every type of cancer making the
use of a 7SK substructure in the inhibition of HMGA1
activity, as pioneered here, potentially useful in
therapy. The 7SK-HMGA1 interaction not only adds
an essential facet to the comprehension of tran-
scriptional plasticity at the coupling of initiation
and elongation, but also might provide a molecular
link between HIV reprogramming of cellular gene
expression-associated oncogenesis.
INTRODUCTION
Small non-coding (nc) RNAs are increasingly recognized
to play crucial roles in both, pre- and post-transcriptional
regulation of gene expression (1). They may act to directly
affect components of the chromatin remodeling (2), the
transcription (3) and translation (4) apparatuses. Also,
ncRNAs have been reported to affect protein stability,
localization and post-translational modiﬁcation (5,6).
Among the best studied ncRNAs involved in pre-
transcriptional regulation is the 7SK RNA. 7SK is a
RNA Polymerase III transcript of 331nt in mammals, be-
longing to the highly abundant small nuclear (sn) RNAs
(7). It is stabilized by a g-monomethylephosphate-GTP
cap on its 50-end, which is synthesized by the
methylephosphate capping enzyme (MePCE) (8,9). The
La-related protein LARP7 has been shown to associate
with the 30-poly(U) region of 7SK RNA, thereby
contributing to the stability of the RNA as well (10).
Recent studies revealed that MePCE and LARP7 act co-
operatively to maintain the integrity of 7SK snRNP (11).
7SK RNA is evolutionary highly conserved among ver-
tebrates (12) and is also found in higher invertebrates,
such as Drosophila melanogaster (13). Since its discovery
in 1976 (14), it took a quarter century until two groups
discovered a key function of 7SK RNA in the regulation
of gene transcription elongation (15,16): 7SK RNA and
HEXIM1 or HEXIM2 bind to the positive transcription
elongation factor b (P-TEFb) and mask its cyclin-
dependent kinase-9 activity, required for cyclin T1 or
T2-mediated phosphorylation of the C-terminal domain
of RNA Polymerase II. Thus, P-TEFb’s role in RNA
Polymerase II transcription elongation is abolished. This
mechanism is thought to establish negative regulatory
control of the RNA Polymerase II elongation activity as
a function of 7SK RNA nuclear concentrations for
P-TEFb-dependent gene expression. Several P-TEFb
target genes have been identiﬁed to date (KLK3, IL8,
CYP1A1, MCL1, CKM, SLC2A4, NR4A1) (17–21),
and P-TEFb is known to play a role in transcription
elongation from the HIV long terminal repeat (22,23).
With little surprise it was recently possible to also place
7SK RNA at the center of Tat-dependent transcription
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to P-TEFb and CDK9 inhibition is well characterized
and understood (25). Loops 1, 3 and 4 of the predicted
secondary structure of 7SK RNA (see Figure 1A) are
thereby directly involved in P-TEFb binding, and serve
as a molecular scaffold for the assembly of the inactive
P-TEFb complex. When P-TEFb is released from 7SK
RNA to activate RNA Polymerase II transcription elong-
ation, these hairpin regions are covered by different heter-
ogenous nuclear ribonucleoproteins (hnRNPs) of distinct
compositions, what is thought to provide a pool of
inactive 7SK RNA (26–28). Loop 2 of the 7SK RNA is
neither required nor involved in P-TEFb, MePCE or
LARP7 interactions. A crucial question remains with
respect to the regulation of this 7SK-dependent inactiva-
tion process. 7SK RNA, as a RNA Polymerase III
transcribed gene, is thought to be expressed at robust
and constant levels through most phases of the cell cycle
and in most embryonic and adult tissues (29). While 7SK
RNA may serve as a buffer to ﬁne-tune P-TEFb to
constant activity, it is conceivable that 7SK RNA tran-
scription itself or the stability, localization and availability
of the RNA are more tightly controlled by yet unidentiﬁed
mechanisms. In this respect, the ﬁnding that P-TEFb
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Figure 1. Puriﬁcation and identiﬁcation of a 7SK L2 binding protein from HeLa nuclear extract. (A) According to its predicted secondary structure
(76), wild-type 7SK RNA can be subdivided into four stem-loop structures: loop1 (L1), loop2 (L2), loop3 (L3) and loop4 (L4). (B) HeLa nuclear
extract was fractionated by cation exchange chromatography (SP-Sepharose Fast Flow), gel ﬁltration (Superdex G75 16/60) and cation exchange
chromatography (SP-Sepharose High Performance), obtaining fractions with a speciﬁc 7SK L2 binding activity (upper scheme). The 7SK L2 binding
activity of the fractions obtained after the ﬁnal SP-Sepharose step was tested by EMSAs (middle panel). The protein content of each of these
fractions was analyzed by silver staining after SDS–PAGE and most likely 7SK binding candidate proteins were identiﬁed by tandem mass spec-
trometry as indicated (lower panel). (C) Increasing amounts of puriﬁed HMGA1a-myc/His (MH) (left panel) and HMGN1-MH (right panel) were
tested for 7SK L2 binding activity compared with 7SK L2 RNA alone ( ). Two nanogram of
32P-labeled 7SK L2 RNA were incubated with  2, 4
and 6ng of puriﬁed HMGA1a-MH (HMGN1-MH) and the resulting complexes were analyzed in EMSAs. (D) Binding of 2ng of
32P-labeled 7SK L2
RNA to  4ng of puriﬁed HMGA1a-MH was competed with increasing amounts of unlabeled 7SK L2 RNA. The resulting complexes were analyzed
in EMSAs compared with 7SK L2 RNA alone ( ).
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vance of 7SK RNA is of great importance. A knockdown
of 7SK RNA in HeLa cells identiﬁed P-TEFb-independ-
ent regulatory phenomena (30). When 7SK RNA concen-
trations are diminished to less than 5%, P-TEFb target
genes are expressed at a higher rate, as expected due to the
higher processivity of the RNA Polymerase II apparatus.
But also gene-expression not regulated by P-TEFb or even
expression from minimal, plasmid-coded promoters is
both positively and negatively altered with changing intra-
cellular concentrations of 7SK RNA. These observations
clearly point to a yet unidentiﬁed second function in tran-
scription regulation exerted by the 7SK snRNA.
We therefore set out to identify additional 7SK interact-
ingproteinsinanefforttounveilsuchP-TEFb-independent
mechanism of gene regulation. We thereby used the loop 2
substructure of 7SK RNA (Figure 1A) as a bait, as this is
the only substructure not involved in P-TEFb, MePCE or
LARP7 binding. We report that the chromatin factor and
transcription regulatory hub HMGA1 is bound by 7SK
RNA,whichinturnaffectsitsDNAbindingandregulatory
activities for over 1500 target genes.
MATERIALS AND METHODS
Cell culture and preparation of extracts
Culturing conditions and transfections. HEK293 and HeLa
cells were cultured as described previously (31). Trans-
fections were either performed by the calciumphosphate
coprecipitation method (32) or by FugeneHD (Roche)
according to the manufacturer’s instructions.
Extract preparations. The preparation of nuclear ex-
tract and total cellular extract was performed as described
previously (33). To obtain extracts for co-immunopre-
cipitation experiments, cells were reconstituted in
isotonic IP-lysis buffer (50mM Tris/HCl, pH 7.4,
150mM NaCl, 1mM ethylenediaminetetraacetic acid
(EDTA), 1% TRITON
TM X-100, protease inhibitor)
and homogenized in a dounce-homogenizer before
cellular debris was removed by high speed centrifugation
(16.000g). The extract was subsequently dialyzed against
IP-buffer (20mM 4-(2-hydroxyethyl)-1-piperazineetha-
nesulfonic acid (HEPES)/KOH, pH 7.9, 100mM KCl,
0.2mM EDTA, 20% glycerol).
Chromatin isolation. Fractionation of cytoplasmic,
soluble nuclear and chromatin-bound proteins was
carried out as descried previously (34). Cells were resus-
pended in two packed cell volumes of lysis buffer (10mM
HEPES/KOH, pH 7.9, 10mM KCl, 1.5mM MgCl2,
340mM sucrose, 1mM dithiothreitol (DTT), 0.1%
TRITON
TM X-100, 10% glycerol, protease inhibitor)
and incubated for 15min on ice. Nuclei were pelleted by
centrifugation (1.300g) and the supernatant containing
cytoplasmic proteins was cleared by centrifugation
(16.000g). After washing once with lysis buffer lacking
TRITON
TM X-100, the soluble nuclear proteins were ex-
tracted by resuspending the nuclei in an equal volume of
extraction buffer (3mM EDTA, 0.2mM
ethyleneglycoltetraacetic acid (EGTA), 1mM DTT,
protease inhibitor) and incubating for 30min on ice.
Chromatin was pelleted by centrifugation (1.700g) and
the soluble nuclear fraction was removed before the
chromatin fraction was washed once with extraction
buffer. Chromatin-bound proteins were eluted by incuba-
tion with SDS–PAGE loading buffer for 10 min at 95 C.
The protein concentration of each fraction was detected as
described previously (35).
Fluorescence microscopy
Mitochondria were stained with Mito-FluorTMRed 594
(Invitrogen) as recommended by the manufacturer.
Fluorescence microscopy was performed using a TCS
SP2 confocal microscope (Leica) and the obtained data
were analyzed using Confocal Software TCS SP2 (Leica).
Molecular biology and RNA biochemistry
Western blot analyses and antibodies. SDS–PAGE and
silver staining was performed as described previously
(36). Antibodies used in western blot analyses were M2
anti-FLAG antibody (Sigma), anti-HMGA1 antibody
(Thermo Fisher Scientiﬁc), anti-RAR-a antibody
(Thermo Fisher Scientiﬁc), anti-LARP7 antibody
(ProteinTech) or anti-MePCE antibody (ProteinTech)
with the corresponding secondary horseradish
peroxidase-coupled antibody, either anti-rabbit antibody
(Cell Signaling) or anti-mouse antibody (Sigma) as recom-
mended by the manufacturer. Western blot signals were
quantiﬁed using ImageJ (Version 1.42q) (37).
Immunoprecipitations. Immunoprecipitations of FLAG-
fusion proteins were performed with M2 anti-FLAG
agarose (Sigma) as recommended by the manufacturer.
Brieﬂy, anti-FLAG agarose was incubated with extracts
containing FLAG fusion proteins in IP buffer (20mM
HEPES/KOH, pH 7.9, 100mM KCl, 0.2mM EDTA,
20% glycerol) for 2h at 4 C. The agarose was pelleted
by centrifugation and the supernatant was removed.
After washing three times with the 20-fold volume of
IP washing buffer (20mM HEPES/KOH, pH 7.9,
100mM KCl, 0.2mM EDTA, 0.025% Tween 20), the
HMGA1a-FLAG bound compounds were eluted in two
steps with the 5-fold volume of IP buffer containing
increasing concentrations of KCl (500mM and 1M),
before the FLAG fusion protein was eluted with the
5-fold volume of elution buffer (100mM glycine/HCl,
pH 3.5). To detect RNA in the elution steps by northern
blot analyses, these fractions were extracted with phenole/
chloroforme and the RNA was subsequently precipitatied
with ethanol. In case the FLAG fusion protein was
puriﬁed for downstream EMSAs, the elution fraction at
pH 3.5 was subsequently dialyzed against IP buffer before
use in EMSAs.
Puriﬁcation of myc-His fusion proteins. HMGA1a-MH
was puriﬁed using Ni-NTA agarose (Qiagen) as recom-
mended by the manufacturer. The extract containing
myc-His fusion proteins was adjusted to 400mM KCl
and 5mM imidazole, before it was incubated with
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pelleted by centrifugation and the supernatant was
removed. After washing twice with the 20-fold volume
of washing buffer (20mM HEPES/KOH, pH 7.9,
400mM KCl, 1mM MgCl2, 20mM imidazole, 0.2mM
EDTA), the bound proteins were eluted by four elution
steps with the 5-fold volume of elution buffer (20mM
HEPES/KOH, pH 7.9, 400mM KCl, 1mM MgCl2,
250mM imidazole, 0.2mM EDTA). The elution fractions
were subsequently dialyzed against IP buffer before use
in EMSAs.
Electrophoretic mobility shift assays. For electrophoretic
mobility shift assays (EMSAs),
32P-labeled or Fam6-
labeled RNA or DNA was denatured for 5 min at 75 C
and renatured by cooling slowly down to room tempera-
ture. The nucleic acid was incubated with immuno-
puriﬁed protein in EMSA-buffer (10mM HEPES/KOH,
pH 7.9, 100mM KCl, 5mM MgCl2, 0.25mM DTT,
0.1mM EDTA, 10% glycerol and 2mg yeast tRNA per
lane) for 10 min at 37 C and subsequently for 10 min on
ice. The resulting complexes were separated by 10% native
PAGE and visualized by autoradiography (
32P) or at
UV light (Fam6). For competition experiments in
EMSAs, a double-stranded DNA oligonucleotide with
the sense sequence 50-GGA AGG AAA CCA AGG
GGC GGA CCC AAA AAA CTG GAG-30 was used.
The double-stranded, Fam6-labeled IL2-Ra promoter
fragment used for competition experiments in EMSAs
had the sense sequence 50-ACC GCA AAC TAT ATT
GTC ATC AAA AAA AAA AAA AAA AAA ACA
CTT CCT ATA TTT GAG ATG-30.
Afﬁnity puriﬁcation with oligo dT-cellulose. For afﬁnity
puriﬁcation with poly-adenylated 7SK L2 RNA, oligo
dT-cellulose (Boehringer) was prepared as recommended
by the manufacturer. Brieﬂy, the freshly renatured
poly-adenylated RNA was incubated for 20 min at 4 C
with oligo dT-cellulose equilibrated against oligo-dT
wash-buffer (10mM HEPES/KOH, pH 7.9, 100mM
KCl, 5mM MgCl2, 0.1mM EDTA, 0.25mM DTT).
Cellular extract containing HMGA1a-FLAG fusion
protein was applied to the column containing the loaded
oligo-dT cellulose and the ﬂowthrough was collected.
After washing with the 25-fold volume of oligo-dT
wash-buffer, the RNA-bound components were eluted
by addition of one volume of oligo-dT wash buffer con-
taining 1mg/ml RNaseA. The protein contents of each
fraction were analyzed in western blot experiments.
Total RNA preparation. Total RNA from transfected
or non-transfected cells was either prepared as described
previously (38) or using the RNeasy Midi Kit (Qiagen) as
recommended by the manufacturer.
In vitro transcription. In vitro transcription analyses were
performed either using nuclear extract from HeLa
cells (33) or using T7 RNA Polymerase (NEB) as recom-
mended by the manufacturer. To label RNA with
32P, the
reaction mixture contained a 10-fold excess of
32P-labeled
a-uridine-50-triphosphate.
Northern blot analyses. Northern blot analyses were
performed as described previously (31) using speciﬁc
32P-labeled antisense RNA probes complementary to the
ﬁrst 89nt of wild-type 7SK or U6 RNA. To detect EBER2
7SK L2, EBER2 7SK L2 m137, EBER2 7SK L2 m122/
m137 RNA, EBER2-Lb RNA as well as wild-type EBER2
RNA a RNA probe complementary to the ﬁrst 77nt of
wild-type EBER2 RNA was utilized.
Chromatographic extract fractionation
Approximately 100 mg of nuclear extract from HeLa cells
was fractionated by cation exchange chromatography
(SP-Sepharose Fast Flow, Amersham), gel ﬁltration
(Superdex G75 16/60) and cation exchange chromatog-
raphy (SP-Sepharose High Performance, Amersham) as
described by the manufacturer. After loading with the
extract, the SP-Sepharose Fast Flow was washed exten-
sively with wash-buffer (20mM HEPES/KOH, pH 7.9,
100mM KCl, 0.2mM EDTA) and the ﬂowthrough was
collected. The bound proteins were eluted in two steps
with wash buffer containing increasing concentrations of
KCl (340mM and 600mM). The fraction containing the
7SK L2 binding protein was loaded on a gel ﬁltration
column (Superdex G75 16/60) to separate the components
by size. The elution was performed with wash buffer and
the fractions containing the 7SK L2 binding protein were
loaded on a column containing SP-Sepharose High
Performance. After washing with wash buffer, the bound
proteins were eluted by a linear KCl-gradient (from
250mM to 1 M) in wash-buffer (see Figure 1B). The frac-
tions were subsequently dialyzed against IP buffer (20mM
HEPES/KOH, pH 7.9, 100mM KCl, 0.2mM EDTA,
20% glycerol).
Mass spectrometry
Visible silver-stained protein bands on SDS–PAGE were
cut out and proteins were in gel digested according to
Shevchenko et al. (39). Eluted peptides were analyzed by
liquid chromatography (LC) coupled tandem mass spec-
trometry (MS/MS) on a Q-Tof Ulitma (Waters) under
standard conditions. Proteins were identiﬁed by database
search of the peptide fragment spectra using MASCOT as
search engine (39).
RNA structure prediction
The secondary structure of RNA was calculated by
RNAstructure (Version 4.4) (40).
Quantitative PCR analyses
qRT-PCR analyses were performed using SuperScript
TM 2
Reverse Transcriptase (Invitrogen), Lightcycler (Roche)
and Fast Start DNA Master
PLUS SYBR Green I reaction
mix (Roche) as recommended by the manufacturer.
Primers used to quantify the housekeeping gene ubiquitin
were 50-GTT GAG ACT TCG TGG TGG TG-30 (sense)
and 50-TCT CGA CGA AGG CGA CTA AT-30 (anti-
sense). Primers used to quantify endogenous HMGA1
2060 Nucleic Acids Research, 2011,Vol.39, No. 6were 50-TCC CAG CCA TCA CTC TTC-30 (sense) and
50-CTC CTT CTG ACT CCC TAC C-30 (antisense).
Transcriptome analyses
For microarray analyses, RNA ampliﬁcation, labeling,
hybridization and detection were performed following
the protocols supplied by Applied Biosystems using the
corresponding kits (Applied Biosystems, ProdNo:
4339628 and 4336875). The data obtained were analyzed
as described previously (31,41–44). Transcriptome data,
annotated to MIAME I+II standards, were deposited in
the public database MACE using Accession Nos.:
2970966830 (HMGA1), and 2979879726 (7SK) (http://
mace.ihes.fr).
Probability calculation
To calculate the random expectation to obtain a given
number of probes returning statistically signiﬁcant fold
changes in response to HMGA1 and EBER2 7SK L2, a
hypergeometric distribution was used:
PðX ¼ xÞ¼
Cx
mCk x
n m
Ck
n
where m is the number of possible successes, n is the total
number of elements, k is the sample size and x is the
number of successes in the sample.
Constructs used in this study
EBER2 7SK L2 fusion transcripts. The EBER2 gene from
 171nt to+226nt containing the complete viral promoter
sequence was cloned into the EcoRI and HindIII restric-
tion sites of PUc18 vector (Fermentas). This clone was
used to construct all EBER2 7SK L2 RNA chimeras.
To obtain the EBER2 7SK L2 construct, the sequence
from +81nt to +140nt of wild-type EBER2 RNA was
exchanged by the sequence from +113nt to +154nt of
wild-type 7SK RNA. To obtain the EBER2 7SK L2
m137 construct, nucleotides +104 to +106 (CGG) of the
EBER2 7SK L2 construct were mutated to GCC. In
the construct EBER2 7SK L2 m122/m137, in addition
the nucleotides +89 to +91 (CCG) were mutated to
GGC. To obtain the EBER2-Lb construct, nucleotides
+80 to+145 of wild-type EBER2 RNA were deleted.
HMGA1a-FLAG, HMGA1a 3xDA/T-FLAG,
HMGA1aDA/T1-FLAG, HMGA1aDA/T2-FLAG and
HMGA1aDA/T3-FLAG. To obtain a vector for the ex-
pression of FLAG fusion proteins, the hybridized oligo-
nucleotides 50-CTA GAG GGC GAC TAC AAA GAC
GAT GAC GAC AAA GGA TGA A-30 (sense) and 30-TC
CCG CTG ATG TTT CTG CTA CTG CTG TTT CCT
ACT TGG CC-50 (antisense) were inserted into the XbaI
and AgeI restriction sites of the vector pcDNA4/TO/
myc-his B (Invitrogen). The coding sequence of
wild-type HMGA1a from +1nt to +321nt was inserted
into the PstI and XbaI restriction sites of the vector men-
tioned above. To obtain the HMGA1a 3xA/T-FLAG
construct, nucleotides+82,+178 and+256 (A,C,A) were
mutated to G in order to change the codons at
these positions from arginine to glycine. To obtain the
single mutants HMGA1aA/T1-FLAG, HMGA1aA/
T2-FLAG and HMGA1aA/T3-FLAG, the single
nucleotides +82, +178 or +256 were mutated to G,
respectively.
HMGA1a-myc/His (MH). The coding sequence of
wild-type HMGA1a from +1nt to +321nt was inserted
into the PstI and XbaI restriction sites of the vector
pcDNA4/TO/myc-his B (Invitrogen).
ShRNA knockdown of HMGA1. To knock down the ex-
pression of endogenous HMGA1, we used the expression
of short hairpin RNA containing a functional siRNA
sequence targeting HMGA1 mRNA (45). The full
sequence of the HMGA1 targeting shRNA was 50-CAA
CUC CAG GAA GGA AAC CAA GCG AUU GGU
UUC CUU CCU GGA GUU G-30. For control, a non-
targeting (scramble) shRNA was used with the sequence
50-AAC AGU CGC GUU UGC GAC UGG GCG ACC
AGU CGC AAA CGC GAC UGU U-30. For down-
stream transcriptome analyses, these shRNAs were ex-
pressed using a vector coding for the corresponding
shRNA under control of the 7SK promoter. To verify
the functionality of the shRNAs, we used a vector
coding for both—the corresponding shRNA under
control of a H1 promoter as well as the HMGA1a-GFP
fusion protein under control of a CMV promoter. Effects
of the corresponding shRNA on the expression of
HMGA1a-GFP fusion protein were followed by ﬂuores-
cence microscopy.
Localization studies of HMGA1a. To study the localiza-
tion of HMGA1a-GFP fusion proteins during a simultan-
eous expression of EBER2 7SK L2 RNA chimeras, a
vector was used that codes for both the corresponding
EBER2 7SK L2 RNA chimera as well as the HMGA1a-
GFP fusion protein under control of a CMV promoter.
To obtain such an expression vector, the coding sequence
of HMGA1a from+1nt to+321nt was inserted into the
XhoI and KpnI restriction sites of the peGFP N1 vector
(clontech). Subsequently, thecodingsequence aswellasthe
complete promoter region of the corresponding RNA
chimera from  171nt to +206nt was inserted into the
EcoR109I restriction site of the obtained HMGA1a-GFP
expression vector. The expression of the EBER2 7SK L2
RNA chimeras was veriﬁed by northern blot analyses and
the expression of HMGA1a-GFP fusion protein was
veriﬁed by ﬂuorescence microscopy. Localization studies
were performed by confocal microscopy.
RESULTS
Fractionation of cellular proteins probed for 7SK
interaction
In order to identify additional, speciﬁc interaction partners
of the human 7SK RNA, we concentrated on the sole pre-
dicted stem-loop structure (loop 2, comprising 110–172nt
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involved in the regulation of P-TEFb activity (46,47) nor
in the interaction with MePCE or LARP7 (9,10). HeLa
nuclear extracts were fractionated by cation exchange
chromatography (SP-Sepharose Fast Flow) into three frac-
tions eluting at 100mM, 340mM and 600mM KCl. Each
fraction was probed for 7SK L2 RNA-binding activity in
EMSAs, revealing that the 600mM KCl fraction contained
a protein binding to 7SK L2. Following, the compounds of
this fraction were separated by size via gel ﬁltration
(Superdex G75). The resulting fractions containing the
7SK L2 binding protein were loaded on a second cation
exchange chromatography (SP-Sepharose High
Performance) and proteins were eluted applying a linear
KCl gradient from 250mM KCl to 1 M KCl (Figure 1B,
upper scheme). Each fraction was analyzed for the
presence of 7SK L2 RNA-binding proteins in EMSAs
(Figure 1B, middel panel). Almost homogeneous protein
fractions with 7SK RNA L2-binding activity were
obtained (Fractions 14–16 from the second cation
exchange chromatography; Figure 1B, middel panel).
Gradient polyacrylamide gel electrophoresis of these frac-
tions revealed three potential candidates for the 7SK
L2-binding protein (Figure 1B, lower panel). LC–MSMS
analysis of the visible proteins revealed that they belong to
the high mobility group proteins HMGN1, HMGA1 and
HMGN2 (see Table 1). Alternative splicing of the
HMGA1 gene transcript leads to three different splice
variants HMGA1a (11.7kDa), HMGA1b (10.6kDa) and
HMGA1c (19.7kDa) (48,49). HMGA1b and c differ from
the major variant by an internal deletion of 11 amino acids
or a frame-shift before the third DNA-binding motif, re-
spectively. In the LC–MSMS analysis of the protein band
matching, the elution proﬁle of the 7SK L2 binding protein
of only the splice variants a and b were detected (Table 1).
To include also the 11 amino acids lacking in HMGA1b
compared to HMGA1a as potential interaction site, for all
following experiments recombinant HMGA1a protein or
HMGA1a cDNA was used. Recombinant variants of the
two most likely candidates, HMGA1 and HMGN1, were
screened for 7SK L2 binding in EMSAs. While HMGN1
did not show any complex formation with 7SK L2 RNA,
we were able to identify HMGA1 as the 7SK L2-binding
protein (Figure 1C). Furthermore, increasing amounts of
unlabeled 7SK L2 RNA compete with the labeled 7SK L2
RNA for binding to HMGA1 in EMSAs, conﬁrming the
speciﬁcity of the complex (Figure 1D).
HMGA1 speciﬁcally binds 7SK RNA in vitro
We disrupted the secondary structure of the terminal
stem-loop region of the wild-type 7SK RNA by
mutation of three nucleotides (137–139nt; Figure 2A;
7SK L2 m137). EMSAs of the mutated RNA revealed a
strong reduction of HMGA1a binding which was not re-
covered by compensatory mutations of the complemen-
tary strand (122–124nt; Figure 2A; 7SK L2 m122/
m137), though such a rescue should partially restore the
original secondary structure. HMGA1a binding thus
occurs via the terminal stem-loop structure of L2 and
the interaction is furthermore speciﬁc to either the
tertiary structure or the sequence of the 7SK RNA. As
increasing amounts of unlabeled 7SK L2 RNA compete
with labeled 7SK L2 RNA for HMGA1a binding
(Figure 1D), these results taken together conﬁrm the spe-
ciﬁcity of that RNA–protein interaction.
7SK RNA interacts with HMGA1 through the 1st
A/T hook
HMGA1a is a DNA binding protein containing three A/T
hook motifs (50). The GFP fusion protein of a HMGA1
mutant (HMGA1a 3xA/T) carrying single R!G
Table 1. HMG proteins identiﬁed by their corresponding peptides in LC–MSMS
Protein MWr MWr calc. Peptide Position
HMGN1 810.54 810.50 LSAKPPAK 24–31
946.50 946.51 KVSSAEGAAK 4–15
1116.60 1116.54 QAEVANQETK 62–71
1301.72 1301.65 VSSAEGAAKEEPK 6–18
1462.95 1462.89 LSAKPPAKVEAKPK 24–37
1676.79 1676.74 TEESPASDEAGEKEAK 83–98
HMGA1a/b 816.35 816.43 SSQPLASK 8–15
982.44 982.50 EPSEVPTPK 47–55
1201.53 1201.63 SSQPLASKQEK 8–18
1391.69 1391.75 EPSEVPTPKRPR 47–58
1731.77 1731.86 SSQPLASKQEKDGTEK 8–23
HMGA1a 1592.77 1592.38 KQPPVSPGTALVGSQK 31–46
2557.17 2557.38 KQPPVSPGTALVGSQKEPSEVPTPK 31–55
HMGA1b 1560.77 1560.85 KQPPKEPSEVPTPK 31–44
HMGN2 1216.53 1216.64 KAEGDAKGDKAK 5–16
1225.60 1225.69 AKVKDEPQRR 15–24
1388.49 1388.65 TDQAQKAEGAGDAK 77–90
1583.81 1583.94 LSAKPAPPKPEPKPK 28–42
After SDS–PAGE and silver staining (see Figure 1B, lower panel), protein bands were excised from the gel, digested enzymatically and the resulting
peptides were analyzed by LC–MSMS. The experimentally determined relative molecular weight (MWr), the calculated relative molecular weight
(MWr calc.), the amino acid sequence of the corresponding peptide as well as the position of this peptide within the corresponding protein are
indicated. The corresponding proteins were identiﬁed by database search of the peptide fragment spectra using MASCOT as search engine.
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ously shown to abrogate DNA binding (51), shows a
strongly decreased chromatin-associated nuclear distribu-
tion compared with the wild-type GFP fusion protein
(Figure 2B).
We veriﬁed this loss of DNA-binding activity of
HMGA1a 3xA/T compared with wild-type HMGA1a
in EMSAs with a promoter fragment (bp  136 to  76)
of the interleukin 2 receptor a gene (IL2-Ra), which has
been previously shown to contain deﬁned HMGA1-
binding sites (52,53).
EMSAs with 7SK L2 RNA revealed that HMGA1a
3xA/T shows not only a decreased DNA-binding
activity but also a signiﬁcantly reduced ability to
interact with 7SK L2 RNA (Figure 2C). Furthermore,
EMSAs of 7SK L2 RNA with HMGA1 versions con-
taining mutations of each single A/T-hook motif
(HMGA1a A/T1, HMGA1a A/T2 and HMGA1a
A/T3) identify the ﬁrst A/T-hook motif of HMGA1a
as the site of interaction with 7SK RNA (Figure 2C,
upper panel), since the same reduction in binding
afﬁnity is observed with the single HMGA1a A/T1
mutant as with the triple mutant. Moreover, mutation
of either one of the remaining A/T hooks does not
reduce 7SK-binding in EMSAs when compared to the
wild-type HMGA1 protein (Figure 2C, upper panel).
Load controls thereby conﬁrm the use of equal
amounts of HMGA1 and mutant proteins in the reac-
tions (Figure 2C, lower panel).
HMGA1 co-puriﬁes speciﬁcally with 7SK RNA
To verify a speciﬁc interaction of full length 7SK RNA
with HMGA1a in vitro, we immuno-precipitated puriﬁed
HMGA1a-FLAG in the presence of in vitro transcribed
7SK, U6 and EBER2 RNA. After extensive washing, the
protein-bound RNA was eluted with increasing concen-
trations of KCl (500mM for E1 and 1 M for E2), before
the FLAG fusion protein was eluted at pH 3.5 (E3). The
RNA contents of each immuno-precipitation step were
analyzed by denaturing PAGE (Figure 3A), revealing
that only 7SK RNA was detectable in the elution fractions
containing increasing concentrations of KCl. Neither U6
Figure 2. The 7SK-HMGA1 interaction is speciﬁc for the secondary structure of 7SK L2 and the A/T-hook motif 1 of HMGA1a. (A) The secondary
structure of 7SK L2, 7SK L2 m137 and 7SK L2 m122/m137 RNA was calculated using RNAstructure 4.4 software (40). The nucleotides are
numbered corresponding to their position in wild-type 7SK RNA. The region mutated in 7SK L2 m137 as well as 7SK L2 m122/m137 RNA is
marked in grey (upper scheme). Two nanogram of each of these
32P-labeled RNAs were tested for HMGA1a-Myc/His (MH) binding activity in
EMSAs using increasing amounts of puriﬁed HMGA1a-MH ( 4 and 8ng), in comparison with the corresponding RNA alone ( ) (lower panel).
(B) The intracellular localization of wild-type HMGA1a-GFP and the mutant HMGA1a 3xA/T-GFP containing three A/T-hook motifs with
disrupted DNA binding activity was analyzed by confocal microscopy. Mitochondria were stained to visualize the cell body. (C) The IL2-Ra
promoter consisting of the basepairs  136 to  6 of the human IL2-Ra gene was used to compare the DNA-binding activity of
HMGA1a-FLAG with HMGA1a 3xA/T-FLAG. EMSAs were performed with 100ng of Fam6-labeled DNA and  100ng of each protein in
comparison to the DNA fragment alone ( ). (D) Hundred nanogram of Fam6-labeled 7SK L2 RNA were incubated with increasing amounts
( 50 and 100ng) of immuno-puriﬁed HMGA1a-FLAG, the A/T-hook mutant HMGA1a 3xA/T-FLAG or single A/T-hook motif mutants
(HMGA1a A/T1-FLAG, HMGA1a A/T2-FLAG, HMGA1a A/T3-FLAG). The resulting complexes were analyzed in EMSAs in comparison
to the RNA alone (-) (upper panel). The amount of protein used in these analyses was veriﬁed by western blot analyses (lower panel).
Nucleic Acids Research,2011, Vol.39, No. 6 2063nor EBER2 snRNAs were obtained. Thus, not only the L2
substructure but also the entire 7SK RNA can bind spe-
ciﬁcally to HMGA1, which in turn does not interact with
the other control RNAs tested.
Vice versa, oligo-dT cellulose was ﬁrst loaded with
polyadenylated 7SK L2 RNA as bait and then incubated
with cellular extracts containing the recombinant
HMGA1a-FLAG fusion protein, efﬁciently enriched
HMGA1 protein from a HEK293 cellular extract. This
is evident from the western blot analysis of the eluted
fraction, obtained after extensive washing and RNase
A digestion (Figure 3B).
7SK RNA interacts with HMGA1 in vivo
To prove the interaction in a cellular context,
HMGA1a-FLAG was immunoprecipitated from transi-
ently transfected HEK293 cells (Figure 3C, upper panel),
and co-puriﬁed RNAs were analyzed in northern blots
utilizing RNA probes speciﬁc for 7SK or U6 RNA
(Figure 3C, lower panels). It is evident that signiﬁcant
amounts of cellular 7SK RNA were released but not
spliceosomal U6 RNA, which served as an internal
control. Hence, the interaction between 7SK RNA and
HMGA1 in vitro remains detectable even in the presence
of high amounts of both competing cellular proteins and
competing cellular RNAs. Since the majority of cellular
7SK RNA is known to be associated with LARP7 by its
30-poly(U) tail (10) and MePCE by its 50-end (8,9), we
tested each fraction of this co-immunoprecipitation for
the presence of these proteins. Indeed, we could conﬁrm
the association of LARP7 as well as MePCE with the
HMGA1-7SK RNA complex. Both proteins elute at
500mM KCl from the HMGA1a-FLAG fusion
protein—in the same fraction as 7SK RNA (Figure 3D).
HMGA1a was described as the ‘hub’ of nuclear
function for being involved in the majority of decisive
nuclear events through its chromatin and gene expression
regulation activities (48,49,54). The ﬁnding that HMGA1
speciﬁcally interacts with 7SK RNA via its A/T-hook 1
DNA binding motif points to a regulatory function of this
novel snRNA–protein complex.
In order to unveil that biological function, we
controlled the amount of free endogenous HMGA1a by
over-expression of the 7SK L2 substructure. For that, the
promoter of the viral EBER2 snRNA gene was used,
which is one of the strongest RNA Polymerase III pro-
moters known, resulting in more than 10
7 copies of this
172nt long nuclear transcript per infected cell (55,56)
(Figure 4A; EBER2 RNA). RNA chimeras of EBER2
RNA (1 80nt and 141–172nt) and the 7SK L2 substruc-
ture (113–154nt; EBER2 7SK L2) as well as the two
mutant 7SK RNA L2 substructures (EBER2 7SK L2
m137 and EBER2 7SK L2 m122/m137) were generated
(Figure 4A). Those constructs exclude any effects on
P-TEFb activity as the chimeras lack the 7SK substruc-
tures L1, L3 and L4 required for P-TEFb binding (46,47)
(Figure 1A). EBER2 7SK L2 chimeras express to high
levels, as checked by both in vitro transcription analysis
and northern blot analysis (Figure 4C). The speciﬁcity
of the antisense RNA probes used in these northern
blot analyses as well as in the experiments shown in
Figure 3C was veriﬁed in northern blot analysis using
in vitro transcripts as well as total cellular RNA
(Figure 4B). Furthermore, EMSAs veriﬁed that
Figure 3. Full length 7SK RNA binds to HMGA1a-FLAG and en-
dogenous 7SK RNA is associated with HMGA1a-FLAG in living
cells. (A) Full length T7-transcribed,
32P-labeled 7SK RNA was
co-immunoprecipitated with puriﬁed HMGA1a-FLAG in vitro by
anti-FLAG agarose. The supernatant (S) was removed and after
washing three times (W), the bound RNA was eluted (E) using
increasing concentrations of KCl (500 mM for E1 and 1 M for E2),
before HMGA1a-FLAG was eluted at pH 3.5 (E3). Every step was
analyzed for RNA by denaturing gel electrophoresis. T7-transcribed,
32P-labeled U6 RNA and viral EBER2 RNA as well as an immunopre-
cipitation lacking HMGA1a-FLAG ( ) were used for control.
(B) Oligo dT-cellulose was loaded with poly-adenylated 7SK L2
RNA. Cellular extract containing HMGA1a-FLAG (+) was added
and after extensive washing (W), the RNA-bound proteins were
eluted by RNaseA digest (E). Unloaded oligo dT-cellulose treated
with cellular extract containing HMGA1a-FLAG was used in a
parallel procedure for control ( ). Flowthrough (F), washing steps
(W) and elution steps (E) were tested for HMGA1a-FLAG by
western blot analyses. (C) Endogenous 7SK RNA was
co-immunoprecipitated with HMGA1a-FLAG from HEK293 cellular
extract by anti-FLAG agarose. After washing three times (W), the
protein-bound RNA was eluted (E) using increasing concentrations of
KCl (500 mM for E1 and 1M for E2), before the HMGA1a-FLAG was
eluted at pH 3.5 (E3). Extract (Ex), supernatant (S), washing steps and
elution steps were tested for HMGA1a-FLAG by western blot analyses.
Co-immunoprecipitated 7SK RNA was visualized by northern blot
analyses (middle panel). U6 RNA (lower panel) as well as an
immunoprecipitation of HEK293 extract lacking HMGA1a-FLAG
( ) was used for control. (D) MePCE and LARP7
co-immunoprecipitate with 7SK RNA and HMGA1a-FLAG. The frac-
tions of the immunoprecipitation shown in (C) were analyzed for
MePCE and LARP7 by western blot analyses.
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tures are entirely retained in the context of the EBER2
chimeras (Figure 4D). Thus neither the EBER2 backbone
(31) inﬂuences the afﬁnity of the L2 RNAs for HMGA1a
nor do parts or the entire EBER2 RNA bind to HMGA1a.
7SK RNA competes with DNA for binding to HMGA1
High HMGA1 expression levels have been reported for
both, embryonic and transformed neoplastic cells
(57–61). The protein is readily detectable in the human
adenovirus ﬁve transformed embryonic cell line HEK293,
using immunocytochemistry as well as RT–PCR analysis.
Recombinant HMGA1a-GFP, co-expressed from the
same plasmid as the EBER2 7SK L2 m137 RNA mutant
in HEK293 cells (Figure 5A), shows a nuclear, chromatin-
associated localization (Figure 5B, lower panels), compar-
able to HMGA1a-GFP alone (Figure 5B, upper panels).
Simultaneous expression of EBER2 7SK L2 RNA and
HMGA1a-GFP results in a less deﬁned nuclear localiza-
tion, concomitant with a signiﬁcantly increased accumula-
tion of the protein within the cytoplasm (Figure 5B, middle
panels). To verify the decrease of chromatin-bound
endogenous HMGA1 upon 7SK L2 over-expression, a
chromatin preparation was performed from HeLa cells
over-expressing EBER2 7SK L2 RNA or EBER2-Lb
RNA. The amounts of chromatin-bound HMGA1 were
compared with non-transfected cells in western blot
Figure 4. EBER2 7SK L2 fusion RNAs express at high levels and conserve HMGA1 binding activity. (A) The secondary structures of EBER2-Lb
RNA, EBER2 7SK L2 RNA, EBER2 7SK L2 m137 RNA, EBER2 7SK L2 m122/m137 RNA as well as EBER2 wild-type RNA was calculated
using RNAstructure 4.4 software (40). The 7SK L2 substructure is highlighted in grey and the region mutated in 7SK L2 m137 as well as 7SK L2
m122/m137 RNA is marked in dark grey. (B) The RNA probes used to detect 7SK, U6 and EBER2 RNA in northern blot analyses were tested for
speciﬁcity. Northern blot analyses were performed with T7-transcribed 7SK, U6 and EBER2 RNA as well as with total cellular RNA using equal
amounts of the
32P-labeled probes targeting 7SK, U6 and EBER2 RNA. (C) The transcription rate of EBER2 7SK L2, EBER2 7SK L2 m137,
EBER2 7SK L2 m122/m137 RNA as well as of EBER2-Lb RNA was compared with wild-type EBER2 RNA in in vitro transcription analyses using
HeLa nuclear extract (upper panel). The in vivo expression was checked in northern blot analyses using a
32P-labeled probe speciﬁc for the 5-region
of EBER2 RNA (lower panel). (D) Two nanogram of
32P-labeled EBER2 7SK L2, EBER2 7SK L2 m137, EBER2 7SK L2 m122/m137, EBER2-Lb
and wild-type EBER2 RNA were incubated with increasing amounts of immuno-puriﬁed HMGA1a-FLAG fusion protein ( 4 and 8ng). The
resulting complexes were analyzed in EMSAs compared with the corresponding RNAs alone ( ). The HMGA1a-binding afﬁnity of the correspond-
ing RNAs is visualized as color code (green=high afﬁnity, orange=medium afﬁnity, red=low afﬁnity). The arrow points at the resulting complex
of EBER2 7SK L2 RNA with HMGA1a-FLAG.
Nucleic Acids Research,2011, Vol.39, No. 6 2065analyses (Figure 5C, upper panel). The quantiﬁcation of
the western blot signals revealed a reduction of the
amount of chromatin-bound endogenous HMGA1 of
about 50% upon EBER2 7SK L2 RNA expression
(Figure 5D). The amount of chromatin-bound RAR-a,
which served as an internal control in these experiments
did not change signiﬁcantly among the different conditions
(Figure 5D). These data corroborate the hypothesis of a
competitive mechanism of HMGA1a binding either to
DNA or 7SK RNA. Indeed, using EMSAs, competitive
binding of 7SK RNA and DNA to HMGA1 can be
demonstrated, as the presence of increasing amounts of
non-labeled dsDNA reduces the amount of complex
formed by HMGA1a and 7SK L2 RNA (Figure 5F and
G). Interestingly, the competition can be speciﬁcally traced
to the 7SK interacting A/T hook 1, as it also readily occurs
in the HMGA1a A/T2, leaving only A/T-hook 1 avail-
able for DNA and RNA interaction, since the A/T-hooks
1 and 2 have been shown previously to be the main medi-
ators of DNA binding (Figure 5F and G) (51). Hence, the
competition also does not rely on unspeciﬁc steric hin-
drance. EMSAs with the promoter region (bp  136 to
 76) of the interleukin 2 receptor alpha (IL2-Ra) gene,
which has been shown previously to contain several
HMGA1 binding sites (52,53), and HMGA1a-FLAG in
the presence of increasing amounts of non-labeled 7SK
L2 RNA conﬁrm the competition of 7SK L2 RNA with
DNA for HMGA1 binding (Figure 5E). The competition
Figure 5. 7SK RNA competes with DNA for HMGA1 binding. (A) Schematic drawing of the constructs used for simultaneous expression of
EBER2 7SK L2 RNA chimeras and HMGA1a-GFP fusion protein. The corresponding promoter elements are highlighted. (B) The intracellular
localization of HMGA1a-GFP alone ( ) as well as in co-expression with EBER2 7SK L2 RNA or EBER2 7SK L2 m137 RNA was analyzed by
confocal microscopy. Mitochondria were stained to visualize the cell body. (C) 7SK L2 over-expression leads to a reduction of chromatin-bound
HMGA1. HeLa cells over-expressing EBER2-Lb RNA and EBER2 7SK L2 RNA as well as non-transfected control cells were fractionated into
cytoplasmic (C), soluble nuclear (sN) and chromatin-bound nuclear fraction (N). The presence of HMGA1 in each fraction was tested in western blot
analyses. RAR-a was used as a control. (D) The western blot signals of the chromatin-bound fraction (N) in C were quantiﬁed using ImageJ software
(37) and the ratios of the corresponding signals after expression of EBER2 7SK L2 RNA or EBER2-Lb RNA and the signal of non-transfected cells
were calculated. (E) The IL2-Ra promoter fragment described in Figure 2C was used to study competition between DNA and 7SK L2 RNA or full
length 7SK RNA for HMGA1a-binding. Hundred nanogram of the Fam6-labeled promoter fragment were incubated with  100ng of
HMGA1a-FLAG in the absence ( ) and presence of increasing amounts (500ng and 1mg) of 7SK L2 and full length 7SK RNA. EMSAs were
performed to analyze the resulting complexes. The fractions of shifted DNA were quantiﬁed from three independent experiments, normalized to the
shifted fraction in absence of competitor (lane 1) and indicated at the bottom of the panel. (F) Hundred nanogram of Fam6-labeled 7SK L2 RNA
were incubated with 100ng of HMGA1a-FLAG as well as the mutant HMGA1aA/T2-FLAG in presence of increasing amounts (500ng and 1mg)
of dsDNA. The resulting complexes were analyzed in EMSAs. The fractions of shifted RNA were quantiﬁed from three independent experiments,
normalized, and indicated as in (E). (G) Hundred nanogram of Fam6-labeled 7SK L2 RNA were incubated with  100ng of HMGA1aA/
T2-FLAG in the presence of increasing amounts (500ng and 1mg) of dsDNA containing a speciﬁc HMGA1 binding motif (77). The resulting
complexes were analyzed in EMSAs. The fractions of shifted RNA were quantiﬁed from three independent experiments, normalized and indicated as
in (E).
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of full length 7SK RNA (Figure 5E).
HMGA1 target genes are affected in their expression
by 7SK RNA
We next determined HMGA1 regulated genes in the same
cell line by comparing transcriptome proﬁles obtained
after short hairpin (sh) RNA-mediated knockdown of
HMGA1 and control shRNA transfected cells. shRNA
was designed according to a published, functional
siRNA, targeting HMGA1 (45) and controlled by the
strong cellular 7SK promoter. Expression of that con-
struct resulted in a signiﬁcant knockdown of the endogen-
ous HMGA1 mRNA (Figure 6D). The knockdown
was also veriﬁed on the protein level using, however,
a vector that allows the simultaneous expresion of both
the shRNA as well as HMGA1 fused to GFP (Figure 6A).
The amount of HMGA1a-GFP positive cells after co-
expression of HMGA1 targeting shRNA was compared
with that after co-expression of control shRNA, revealing
a highly signiﬁcant knockdown of the HMGA1a-GFP
fusion protein (Figure 6B and C).
Microarray analysis of RNA from HEK293 cells with
knockdown of endogeneous HMGA1 using three inde-
pendent biological replicates revealed a total of 2449
genes regulated by HMGA1 in a statistically signiﬁcant
way (P<0.01). Most of these genes (2436 or 99%) were
found to be up-regulated upon depletion of HMGA1,
which is in line with the previous observations (48).
Similarly, the relative effect of EBER2 7SK L2 RNA
chimera expression on HEK293 gene transcription as
compared with the EBER2-L2 backbone alone was
determined using ﬁve independent biological replicates.
A total of 2715 genes were identiﬁed to be regulated in a
statistically signiﬁcant manner (P<0.01), when compared
with the control. In all 1649, or 61%, is also statistically
signiﬁcantly (P<0.01) regulated by HMGA1 (Figure 7A).
This common subset corresponds to 67% of the 2449
HMGA1 target genes. Such an extraordinary concordance
(random expectation P<4.9 10
 324, hypergeometric
distribution) between HMGA1 targets and 7SK
L2-responsive genes can only be explained by a strong
and a highly relevant physiological interaction between
both molecules. Importantly, albeit most genes are re-
pressed in their expression by HMGA1, we also identiﬁed
several genes that are positively regulated by HMGA1 and
7SK RNA (Figure 7A). An even stronger indication that
7SK and HMGA1 transcriptional effects are closely
related stems from the observation that the Pearson cor-
relation coefﬁcient for the statistically signiﬁcant
co-regulated subset (R
2=0.71) is comparable to the joint
set of genes regulated by either HMGA1 or 7SK L2
(R
2=0.66), and even to the subsets speciﬁc to either
molecule (R
2=0.63, R
2=0.48) in these completely inde-
pendent experiments (Figure 7A and C). Albeit not
provable due to the limits of statistical testing, the statis-
tical correlations indicate that the HMGA1 and the 7SK
RNA-induced transcriptome proﬁles are not only tightly
linked but identical. The high correlation between gene
expression downstream of HMGA1 and 7SK L2 also
conﬁrms the quality of the experimental techniques
used that were previously thoroughly tested to minimize
unspeciﬁc effects from the EBER2 backbone used for
over-expression of the 7SK L2 substructure (31). To
further investigate the joint gene regulatory activity of
HMGA1 and 7SK RNA, we also compared HEK293
transcriptome proﬁles using the EBER2 7SK L2
wild-type versus the EBER2 7SK L2 m137 mutant,
which shows signiﬁcantly lowered HMGA1 binding
activity (Figure 2A). Again 333 out of 484, or 69%, of
the 7SK L2 regulated genes (P<0.05) were found to be
HMGA1 targets (Figure 7B and D). Thus even when
comparing the 7SK L2 substructure to the 7SK L2
m137 mutant, a large and perfectly concordant set of
HMGA1 targets can be identiﬁed. Due to the residual
binding of the L2-mutant to HMGA1 (Figure 2A), the
relative effect is diminished and harder to appreciate stat-
istically. The common subset of genes differentially
regulated after HMGA1 knockdown as well as after ex-
pression of EBER2 7SK L2 RNA in comparison to
EBER2-Lb RNA (Figure 7A; yellow) is especially
enriched in genes, which are strongly affected by the
HMGA1 knockdown (Figure 8A). In all, 293 (88%) out
of the 333 genes of the common subset differentially ex-
pressed after expression of both, EBER2 7SK L2 RNA in
comparison to EBER2 7SK L2 m137 RNA and the
Figure 6. Knockdown of endogenous and exogenous HMGA1.
(A) Schematic drawing of the constructs used to verify HMGA1 ex-
pression knockdown on protein level. The expression of the corres-
ponding shRNA (HMGA1 targeting or control) was controlled by
the H1 RNA promoter. The target gene (HMGA1) was expressed as
GFP-fusion protein under control of the CMV promoter from the same
vector as the shRNA. (B and C) HMGA1 expression in HEK293 cells
was knocked down by shRNA in comparison to non-targeting control
shRNA. HMGA1a-GFP was co-expressed with either control or
HMGA1 shRNA using plasmids coding for both, shRNA and GFP
fusion protein (see A). HMGA1a-GFP positive cells were counted via
ﬂuorescence microscopy. ***P<0.01 in a Student’s t-test. The error
bars show the SD. (D) The expression of endogenous HMGA1 in
HEK293 cells was knocked down by shRNA in comparison to
non-targeting control shRNA using a vector that allows the expression
of either shRNA under control of the 7SK RNA promoter. The
knockdown of endogenous HMGA1 mRNA was veriﬁed by quantita-
tive PCR analyses. *P<0.05 in a Student’s t-test. The error bars show
the SD.
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common subset of genes differentially expressed after
expression of both, EBER2 7SK L2 RNA in comparison
to EBER2-Lb RNA and HMGA1 knockdown (Figure
8B). Even though not affected in a signiﬁcant manner in
every case, the expression of the genes belonging to both
subsets clearly appears to be linked (Figure 8B). The
overlap of both subsets (Figure 8B; blue) is enriched in
genes, which are strongly affected among the common
subset differentially regulated after HMGA1 knockdown
as well as after expression of EBER2 7SK L2 RNA in
comparison to EBER2-Lb RNA (Figure 8C).
Among the genes regulated differentially by both, the
7SK L2 substructure and the HMGA1-knockdown were
various genes with a linkage to major cellular functions
that are known to be regulated by HMGA1 (60–64). The
expression of several transcription factors (e.g. BTF3,
CNOT3, EP300), cancer-related proteins (e.g. TPT1,
BCL7C, RELA), apoptosis-related proteins (e.g.
BCL2L13) and members of the histone family (e.g.
HIST1H2BL) was found to be signiﬁcantly increased by
the over-expression of 7SK L2 domain as well as by the
HMGA1-knockdown (Figure 9A). Previous studies had
already identiﬁed for instance MAP2K2, IGFBP2,
SOX4, GNAZ, STK6, CCND3, LAMA1, ACSL3,
ARL3, COL6A1 (65), COX2 (64), IFNAR (63) and
HLA-A (62), as HMGA1 target genes which we show
here are also to be 7SK regulated genes. Due to the limi-
tation of over-expression of solely the L2 substructure of
7SK RNA, P-TEFb regulated genes were not supposed to
be targeted by our approach, which is conﬁrmed when
verifying the expression of known P-TEFb target genes
(17–21) (Figure 9B).
DISCUSSION
HMGA1 is crucially involved in the vast majority of
essential nuclear processes (48,49,54) as well as in neoplas-
tic transformation and tumor progression (57–61).
A speciﬁc, functional interaction of 7SK RNA with the
ﬁrst A/T-hook of HMGA1a via its highly conserved loop2
affects HMGA1-DNA binding and consequently
promotes positive or negative regulatory activity. 7SK
RNA hence provides direct regulatory control of
HMGA1 activity. This is, to our knowledge, the ﬁrst
report of a direct affector for HMGA1 function not
acting at the transcriptional or translational level. As
HMGA1 has both positive and negative effects on
Figure 7. The 7SK–HMGA1a interaction impacts the HMGA1a-controlled gene expression. (A and B) The log2-fold change of gene expression after
over-expression of EBER2 7SK L2 RNA (y-axis) is compared with that after a shRNA-mediated knockdown of HMGA1 (x-axis). Either the
over-expression of EBER2-Lb RNA (A) or the over-expression of EBER2 7SK L2 m137 RNA (B) were chosen for control. Genes signiﬁcantly
regulated by both conditions are marked in yellow (red). Those, which are solely regulated signiﬁcantly by the shRNA-mediated knockdown of
HMGA1 are marked in grey and those solely regulated by the 7SK L2 RNA are marked in green (dark grey). (C and D) Heat maps of the joint
subset of statistically signiﬁcant (at least P<0.05) changes in gene expression between HEK293 cells over-expressing EBER2 7SK L2 RNA
compared with EBER2-Lb (C) EBER2 7SK L2 m137 RNA (D) and HEK293 cells with a shRNA-mediated HMGA1-knockdown compared
with HEK293 cells expressing scramble shRNA. L indicates the log2-fold change in expression, S indicates the signal, P indicates the P-value
and the roman numbers indicate independent biological replicates.
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such as the estrogen receptor (ER, positive) or the retino-
blastoma protein (RB) and p53 which are negatively
regulated, the amounts of free 7SK RNA directly affect
a large number of transcription programs and cell cycle
check-points by regulating HMGA1 function. The tran-
scriptional programs of HMGA1 and 7SK RNA that we
identify here and show to be virtually identical will
provide rich information on the multitude of gene
programs at the control of HMGA1 in transformed cells
once analyzed in detail.
The disruption of the HMGA1-7SK snRNA complex
by siRNA-mediated depletion of 7SK RNA in HeLa
cells has led to the observation of signiﬁcant effects on
P-TEFb-independent genes without explanation of the
underlying mechanism (30). The fact that 7SK RNA
provides regulatory control of HMGA1 function is
likely the explanation for the unexpected effects on gene
expression independent of P-TEFb (30), as HMGA1 is
known to interact with AT-rich sequences present in the
minimal promoter-driven reporters used.
As 7SK RNA has a positive regulatory effect on
the large majority of HMGA1 controlled genes, and a
negative regulatory effect on elongation of P-TEFb-
dependent gene expression, 7SK RNA establishes plasti-
city between transcription initiation and transcription
elongation. The relative amounts of free 7SK RNA in
the nucleus, and the opposite effects 7SK RNA has on
both transcription regulators indicates yet another intri-
cate mechanism of ﬁne-tuning within the transcription ap-
paratus. A potential 7SK snRNP containing both P-TEFb
and HMGA1 would raise important questions concerning
possible interlocking functions of HMGA1 and P-TEFb
in gene expression regulation and would directly link the
Figure 8. Comparison of the common subsets of genes regulated differentially between EBER2 7SK L2 and the two different controls (EBER2-Lb
RNA and EBER2 7SK L2 m137 RNA) as well as HMGA1 knockdown and control. (A) The common subset of genes expressed differentially after
HMGA1 knockdown compared to the control were ordered by their log2-fold change (2449 genes in Figure 7A; grey). Those genes also expressed
differentially after EBER2 7SK L2 RNA expression in comparison to the expression of EBER2-Lb RNA are plotted in yellow (1649 genes in
Figure 7A). A density histogram for the enrichment of the yellow versus grey gene sets (bin-size 50 genes)is plotted against the log2-fold change in
gene expression. (B) The common subset of differential gene expression after EBER2 7SK L2 RNA expression compared to EBER2-Lb RNA
expression and HMGA1 knockdown (yellow) is compared to the common subset of differential gene expression after EBER2 7SK L2 RNA
expression compared to EBER2 7SK L2 m137 RNA expression and HMGA1 knockdown (red). Genes signiﬁcantly regulated in both subsets are
marked in blue. For these subsets the log2-fold change of gene expression in each condition is plotted on the x- and y-axis respectively. (C) As (A),
but for the yellow and blue (see (B)) subsets.
Figure 9. Genes with HMGA1 connected major cellular functions are
regulated by the 7SK-HMGA1 interaction. (A) Different genes,
up-regulated by both, over-expression of EBER2 7SK L2 RNA either
compared with over-expression of EBER2 7SK L2 m137 RNA (grey
bars) or compared with over-expression of EBER2-Lb RNA (black
bars) and shRNA-mediated knockdown of HMGA1 (white bars),
sorted by the functions of their gene products. The error bars show
the SD. (B) The expression of P-TEFb-regulated genes (17–21) is not
affected at the chosen conditions.
Nucleic Acids Research,2011, Vol.39, No. 6 2069modiﬁcation of chromatin structure (by HMGA1) to gene
transcription elongation (by T-TEFb). Furthermore, also
possible effects of the hnRNPs, which have been shown to
replace P-TEFb from 7SK RNA, on the HMGA1-7SK
interaction have to be elucidated. In any case, the connec-
tion between P-TEFb-dependent and HMGA1-dependent
signaling via 7SK RNA which we uncovered here repre-
sents a new molecular switch (Figure 10). The role that
P-TEFb and 7SK RNA play in Tat-dependent HIV tran-
scription (24,66–69) thereby might also provide a molecu-
lar explanation for the HIV-associated B-cell lymphoma
and Kaposi sarcoma incident rates (70–73). Increased
titration of nuclear 7SK RNA into Tat-dependent tran-
scription regulatory complexes will, according to our ob-
servations, directly increase HMGA1activity. As increased
HMGA1 activity is associated with virtually every known
type of cancer, the switch function of 7SK RNA might
indeed explain why 7SK RNA is an essential gene.
Interestingly, also is the fact that the 7SK-HMGA1
complex represents a novel link between RNA
Polymerase II and III gene expression programs. While
examples of RNA Polymerase III transcripts affecting
RNA Polymerase II-driven gene expression and RNA
processing, such as the U6 RNA and its role in splicing
(74), exist, the observation of a RNA Polymerase III
transcribed gene directly regulating RNA Polymerase II
transcription initiation on such a large scale, raises im-
portant questions as to the functional inter-dependence
of both transcription machines. Furthermore, renewed
interest should be accorded to the question of regulatory
phenomena in RNA Polymerase III transcription (75). As
non-translated RNAs are rarely quantiﬁed on widely used
microarray technology, and also for technical reasons are
only seldom captured in SAGE analysis, we know too
little about variations in gene expression patterns of
RNA Polymerase III transcripts especially in oncogenesis
and viral infection.
Considering the direct connection between the dere-
pression of HMGA1 and cancerogenesis (57–61), over-
expression of the 7SK L2 substructure might establish a
powerful tool to control the activity of endogenous
HMGA1 in physiopathology. From our works it comes
that regulating 7SK RNA expression will directly, posi-
tively or negatively affect HMGA1 activity (Figure 10).
The plasticity between the control of transcription elong-
ation by P-TEFb and of chromatin and transcription
regulation by HMGA1 established by 7SK snRNA
might be highly relevant for HIV-induced reprogramming
of cellular and viral gene expression, and furthermore
raises important questions regarding the control of RNA
Polymerase III gene transcription (75). The intertwined
regulation via 7SK RNA of the control of transcription
elongation (by P-TEFb) and of the control of gene activity
(by HMGA1) assigns a major role to that snRNA as a
molecular switch for nuclear key functions (Figure 10).
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tagonist of histone 1 (H1). In addition, it also alters the afﬁnity of
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of 7SK RNA into HMGA1 or P-TEFb complexes, respectively.
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